Alicia Pucci

Safety and Immunogenicity of mRNA-1010, an Investigational Seasonal Influenza Vaccine, in Healthy Adults: Final Results From a Phase 1/2 Randomized Trial

Jintanat Ananworanich, Ivan T. Lee, David J. Ensz et al. · The Journal of Infectious Diseases · 2024 · 41 citations · Full text

A phase 3 randomized safety and immunogenicity trial of mRNA-1010 seasonal influenza vaccine in adults

Mieke Soens, Jintanat Ananworanich, Bryony Hicks et al. · Vaccine · 2025 · 34 citations · Full text

An mRNA-based seasonal influenza vaccine in adults: Results of two phase 3 randomized clinical trials and correlate of protection analysis of hemagglutination inhibition titers

Boris Kandinov, Mieke Soens, Wenmei Huang et al. · Human Vaccines & Immunotherapeutics · 2025 · 15 citations · Full text

Safety and immunogenicity of mRNA-based seasonal influenza vaccines formulated to include multiple A/H3N2 strains with or without the B/Yamagata strain in US adults aged 50–75 years: a phase 1/2, open-label, randomised trial

Denise C. Hsu, Akila Jayaraman, Alicia Pucci et al. · The Lancet Infectious Diseases · 2024 · 14 citations

Public Health Efforts Can Impact Adoption of Current Susceptibility Breakpoints, but Closer Attention from Regulatory Bodies Is Needed

James A. McKinnell, Sandeep Bhaurla, P. Marquez-Sung et al. · Journal of Clinical Microbiology · 2018 · 10 citations · Full text